Nicotinic cholinergic receptor deficits in Alzheimer's disease: Where's the smoke?

Journal of Alzheimer's Disease

Volumn 1, Issue 4-5, 1999, Pages 221-230

  Pauly, J R ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; TACRINE;

ALZHEIMER DISEASE; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; SMOKING;

EID: 0033302288     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-14-504     Document Type: Review

References (55)

1. Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function
2. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases
3. Epibatidine, a potent analgetic and nicotinic agonist
4. The cholinergic hypothesis of geriatric memory dysjunction
5. Neuroprotection against oxidative stress by estrogens: Structure activity relationships
6. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain
7. 3H]-nicotine binding sites in human brain
8. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion
9. 3H]-nicotine binding in human postmortem brain
10. 125I]-α-bungarotoxin binding in human postmortem brain
11. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys
12. The fall and rise of neuronal α-bungarotoxin binding proteins
13. 125I]-α-bungarotoxin
14. 3H]-nicotine binding in rat brain: Alteration after chronic acetylcholinesterase inhibition
15. Effects of nicotine on spatial memory deficits in rats with septal lesions
16. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and α2 subunits and is up-regulated by chronic nicotine treatment
17. What we have learned from the THA trials to facilitate testing of new AChE inhibitors
18. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNA's in the basal forebrain and hippocampal formation of adult rats
19. Hippocampal synaptic transmission enhanced by low concentrations of nicotine
20. Corticosterone reversibly alters brain α-bungarotoxin binding and nicotine sensitivity
21. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein-infused rats
22. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease
23. Hippocampal aging and adrenocorticoids: A quantitative correlation
24. The role of glucocorticoids in brain aging and Alzheimer's Disease: An integrative physiological hypothesis
25. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's Disease
26. Nicotinic receptor function in schizophrenia
27. Nicotinic systems and cognitive function
28. Heterogeneity of epibatidine binding sites in mouse brain
29. Nicotine binding and nicotinic receptor subunit rna after chronic nicotine treatment
30. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction
31. 125I]-α-bungarotoxin (2.2 and 3.3) to the suprachiasmatic nucleus of the hypothalamus: An in vivo autoradiographic analysis
32. The role of nicotine and nicotinic mechanisms in neuropshychiatric disease
33. Human nicotinic receptors - Their role in aging and dementia
34. 3H]-cytisine binding in rat and mouse brain
35. An autoradiographic analysis of nicotinic cholinergic receptors following chronic corticosterone treatment
36. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels
37. Chronic nicotine infusions and regulation of CNS nicotinic cholinergic receptors: An autoradiographic study
38. Increased density of neuronal nicotinic receptor subtypes in rats repeatedly exposed to tobacco smoke
39. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover
40. Nicotinic receptors in the development and modulation of CNS synapses
41. Nicotine and tetrahydro-aminoacradine: Evidence for improved attention in patients with dementia of the Alzheimer type
42. Nicotine inhibits amyloid formation by the beta peptide
43. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
44. Estrogenic effects on memory in women
45. 125I]-α-bungarotoxin binding
46. Neuropsychiatric manifestations of patients with Cushing's syndrome
47. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid
48. Cortisol secretion and Alzheimer's disease progression: A preliminary report
49. Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety
50. Presynaptic nicotinic ACh receptors
51. The paradox of nicotinic acetylcholine receptor upregulation by nicotine
52. Distribution of three nicotinic receptor α4 mRNA transcripts in rat brain: Selective regulation by nicotine administration